3D microfluidic ex vivo culture of organotypic tumor spheroids to model immune checkpoint blockade
Open accessAbstract
Microfluidic culture has the potential to revolutionize cancer diagnosis and therapy.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Treatment with an anti-PD-1 antibody showed cancer cell death mediated by CD8 T-cells.
“Treatment with an anti-PD-1 antibody showed cancer cell death mediated by CD8 T-cells.”
From The Tumor-on-Chip: Recent Advances in the Development of Microfluidic Systems to Recapitulate the Physiology of Solid Tumors (2019) · cites this paper as [48]
Patient-derived tumor spheroids retained lymphoid and myeloid subsets of immune cells.
“This study demonstrated that patient-derived tumor spheroids retain lymphoid and myeloid subsets of immune cells and that those cell”
From The Tumor-on-Chip: Recent Advances in the Development of Microfluidic Systems to Recapitulate the Physiology of Solid Tumors (2019) · cites this paper as [48]
Analysis of cytokines revealed a natural evolution of cytokine and growth factor secretion over time (e.g., IL-8, VEGF, IL-12, CCL4).
“Analysis of cytokines (Figure 6c-iv,v) revealed a natural evolution of cytokine and growth factor secretion over time (e.g., IL-8 VEGF, IL-12, CCL4).”
From The Tumor-on-Chip: Recent Advances in the Development of Microfluidic Systems to Recapitulate the Physiology of Solid Tumors (2019) · cites this paper as [48]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
The blockade of immune checkpoints in cancer immunotherapy
Pardoll, D. M. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3239 · Cited by 13,838 · see citing works
Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
Larkin, J., Chiarion-Sileni, V., Gonzalez, R., Grob, J. J., Cowey, C. L., Lao, C. D., Schadendorf, D., Dummer, R., Smylie, M., Rutkowski, P., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1504030 · Cited by 8,157 · see citing works
Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche
Sato, T., Vries, R. G., Snippert, H. J., van de Wetering, M., Barker, N., Stange, D. E., van Es, J. H., Abo, A., Kujala, P., Peters, P. J., et al. (2009) · Nature · doi:10.1038/nature07935 · Cited by 7,204 · see citing works
PD-1 blockade induces responses by inhibiting adaptive immune resistance
Tumeh, P. C., Harview, C. L., Yearley, J. H., Shintaku, I. P., Taylor, E. J. M., Robert, L., Chmielowski, B., Spasic, M., Henry, G., Ciobanu, V., et al. (2014) · Nature · doi:10.1038/nature13954 · Cited by 6,609 · see citing works
Modeling Development and Disease with Organoids
Clevers, H. (2016) · Cell · doi:10.1016/j.cell.2016.05.082 · Cited by 3,196 · see citing works
Nivolumab and ipilimumab versus ipilimumab in untreated melanoma
Postow, M. A., Chesney, J., Pavlick, A. C., Robert, C., Grossmann, K., McDermott, D., Linette, G. P., Meyer, N., Giguere, J. K., Agarwala, S. S., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1414428 · Cited by 2,781 · see citing works
A living biobank of breast cancer organoids captures disease heterogeneity
Sachs, N., de Ligt, J., Kopper, O., Gogola, E., Bounova, G., Weeber, F., Balgobind, A. V., Wind, K., Gracanin, A., Begthel, H., et al. (2018) · Cell · doi:10.1016/j.cell.2017.11.010 · Cited by 1,973 · see citing works
Drost, J., & Clevers, H. (2018) · Nature Reviews Cancer · doi:10.1038/s41568-018-0007-6 · Cited by 1,790 · see citing works
Human primary liver cancer–derived organoid cultures for disease modeling and drug screening
Broutier, L., Mastrogiovanni, G., Verstegen, M. M., Francies, H. E., Gavarró, L. M., Bradshaw, C. R., Allen, G. E., Arnes-Benito, R., Sidorova, O., Gaspersz, M. P., et al. (2017) · Nature Medicine · doi:10.1038/nm.4438 · Cited by 1,471 · see citing works
CDK4/6 Inhibition Augments Antitumor Immunity by Enhancing T-cell Activation
Deng, J., Wang, E. S., Jenkins, R. W., Li, S., Dries, R., Yates, K., Chhabra, S., Huang, W., Liu, H., Aref, A. R., et al. (2018) · Cancer Discovery · doi:10.1158/2159-8290.cd-17-0915 · Cited by 770 · see citing works
Self-citationTranslational value of mouse models in oncology drug development
Gould, S. E., Junttila, M. R., & de Sauvage, F. J. (2015) · Nature Medicine · doi:10.1038/nm.3853 · Cited by 293 · see citing works
Flagged first, then by citations
Research works printed but not linked: 56
- [1]Pardoll DM, Nat Rev Cancer, 2012, 12, 252– 264. 22437870 PMC4856023
- [2]Topalian SL, Drake CG and Pardoll DM, Cancer Cell, 2015, 27, 450– 461. 25858804 PMC4400238
- [3]Carbognin L, Pilotto S, Milella M, Vaccaro V, Brunelli M, Calio A, Cuppone F, Sperduti I, Giannarelli D, Chilosi M, Bronte V, Scarpa A, Bria E and Tortora G, PLoS One, 2015, 10, e0130142. 26086854 PMC4472786
- [4]Mahoney KM, Rennert PD and Freeman GJ, Nat Rev Drug Discov, 2015, 14, 561– 584. 26228759
- [5]Jenkins RW, Barbie DA and Flaherty KT, Br J Cancer, 2018, 118, 9– 16. 29319049 PMC5765236
- [6]Larkin J, Hodi FS and Wolchok JD, N Engl J Med, 2015, 373, 1270– 1271. 26398076
- [7]Postow MA, Chesney J, Pavlick AC, Robert C, Grossmann K, McDermott D, Linette GP, Meyer N, Giguere JK, Agarwala SS, Shaheen M, Ernstoff MS, Minor D, Salama AK, Taylor M, Ott PA, Rollin LM, Horak C, Gagnier P, Wolchok JD and Hodi FS, N Engl J Med, 2015, 372, 2006– 2017. 25891304 PMC5744258
- [8]Marincola FM, Jaffee EM, Hicklin DJ and Ferrone S, Adv Immunol, 2000, 74, 181– 273. 10605607
- [9]Bronte V, Kasic T, Gri G, Gallana K, Borsellino G, Marigo I, Battistini L, Iafrate M, Prayer-Galetti T, Pagano F and Viola A, J Exp Med, 2005, 201, 1257– 1268. 15824085 PMC2213151
- [10]Pitt JM, Vetizou M, Daillere R, Roberti MP, Yamazaki T, Routy B, Lepage P, Boneca IG, Chamaillard M, Kroemer G and Zitvogel L, Immunity, 2016, 44, 1255– 1269. 27332730
- [11]O’Donnell JS, Long GV, Scolyer RA, Teng MW and Smyth MJ, Cancer Treat Rev, 2017, 52, 71– 81. 27951441
- [12]Tumeh PC, Harview CL, Yearley JH, Shintaku IP, Taylor EJ, Robert L, Chmielowski B, Spasic M, Henry G, Ciobanu V, West AN, Carmona M, Kivork C, Seja E, Cherry G, Gutierrez AJ, Grogan TR, Mateus C, Tomasic G, Glaspy JA, Emerson RO, Robins H, Pierce RH, Elashoff DA, Robert C and Ribas A, Nature, 2014, 515, 568– 571. 25428505 PMC4246418
- [13]Taube JM, Young GD, McMiller TL, Chen S, Salas JT, Pritchard TS, Xu H, Meeker AK, Fan J, Cheadle C, Berger AE, Pardoll DM and Topalian SL, Clin Cancer Res, 2015, 21, 3969– 3976. 25944800 PMC4558237
- [14]Carvalho MR, Lima D, Reis RL, Correlo VM and Oliveira JM, Trends Biotechnol, 2015, DOI: 10.1016/j.tibtech.2015.09.009. 26603572 · DOI
- [15]Feder-Mengus C, Ghosh S, Reschner A, Martin I and Spagnoli GC, Trends Mol Med, 2008, 14, 333– 340. 18614399
- [16]Jenkins RW, Aref AR, Lizotte PH, Ivanova E, Stinson S, Zhou CW, Bowden M, Deng J, Liu H, Miao D, He MX, Walker W, Zhang G, Tian T, Cheng C, Wei Z, Palakurthi S, Bittinger M, Vitzthum H, Kim JW, Merlino A, Quinn M, Venkataramani C, Kaplan JA, Portell A, Gokhale PC, Phillips B, Smart A, Rotem A, Jones RE, Keogh L, Anguiano M, Stapleton L, Jia Z, Barzily-Rokni M, Canadas I, Thai TC, Hammond MR, Vlahos R, Wang ES, Zhang H, Li S, Hanna GJ, Huang W, Hoang MP, Piris A, Eliane JP, Stemmer-Rachamimov AO, Cameron L, Su MJ, Shah P, Izar B, Thakuria M, LeBoeuf NR, Rabinowits G, Gunda V, Parangi S, Cleary JM, Miller BC, Kitajima S, Thummalapalli R, Miao B, Barbie TU, Sivathanu V, Wong J, Richards WG, Bueno R, Yoon CH, Miret J, Herlyn M, Garraway LA, Van Allen EM, Freeman GJ, Kirschmeier PT, Lorch JH, Ott PA, Hodi FS, Flaherty KT, Kamm RD, Boland GM, Wong KK, Dornan D, Paweletz CP and Barbie DA, Cancer Discov, 2018, 8, 196– 215. 29101162 PMC5809290
- [17]Deng J, Wang ES, Jenkins RW, Li S, Dries R, Yates K, Chhabra S, Huang W, Liu H, Aref AR, Ivanova E, Paweletz CP, Bowden M, Zhou CW, Herter-Sprie GS, Sorrentino JA, Bisi JE, Lizotte PH, Merlino AA, Quinn MM, Bufe LE, Yang A, Zhang Y, Zhang H, Gao P, Chen T, Cavanaugh ME, Rode AJ, Haines E, Roberts PJ, Strum JC, Richards WG, Lorch JH, Parangi S, Gunda V, Boland GM, Bueno R, Palakurthi S, Freeman GJ, Ritz J, Haining WN, Sharpless NE, Arthanari H, Shapiro GI, Barbie DA, Gray NS and Wong KK, Cancer Discov, 2018, 8, 216– 233. 29101163 PMC5809273
- [18]Aref AR, Huang RY, Yu W, Chua KN, Sun W, Tu TY, Bai J, Sim WJ, Zervantonakis IK, Thiery JP and Kamm RD, Integr Biol (Camb), 2013, 5, 381– 389. 23172153 PMC4039387
- [19]Cejas P, Li L, O’Neill NK, Duarte M, Rao P, Bowden M, Zhou CW, Mendiola M, Burgos E, Feliu J, Moreno-Rubio J, Guadalajara H, Moreno V, Garcia-Olmo D, Bellmunt J, Mullane S, Hirsch M, Sweeney CJ, Richardson A, Liu XS, Brown M, Shivdasani RA and Long HW, Nat Med, 2016, 22, 685– 691. 27111282
- [20]Newman AM, Liu CL, Green MR, Gentles AJ, Feng W, Xu Y, Hoang CD, Diehn M and Alizadeh AA, Nat Methods, 2015, 12, 453– 457. 25822800 PMC4739640
- [21]Clevers H, Cell, 2016, 165, 1586– 1597. 27315476
- [22]Dutta D, Heo I and Clevers H, Trends Mol Med, 2017, 23, 393– 410. 28341301
- [23]Byrne AT, Alferez DG, Amant F, Annibali D, Arribas J, Biankin AV, Bruna A, Budinska E, Caldas C, Chang DK, Clarke RB, Clevers H, Coukos G, Dangles-Marie V, Eckhardt SG, Gonzalez-Suarez E, Hermans E, Hidalgo M, Jarzabek MA, de Jong S, Jonkers J, Kemper K, Lanfrancone L, Maelandsmo GM, Marangoni E, Marine JC, Medico E, Norum JH, Palmer HG, Peeper DS, Pelicci PG, Piris-Gimenez A, Roman-Roman S, Rueda OM, Seoane J, Serra V, Soucek L, Vanhecke D, Villanueva A, Vinolo E, Bertotti A and Trusolino L, Nat Rev Cancer, 2017, 17, 254– 268. 28104906
- [24]Micalizzi DS, Maheswaran S and Haber DA, Genes Dev, 2017, 31, 1827– 1840. 29051388 PMC5695084
- [25]Sato T, Vries RG, Snippert HJ, van de Wetering M, Barker N, Stange DE, van Es JH, Abo A, Kujala P, Peters PJ and Clevers H, Nature, 2009, 459, 262– 265. 19329995
- [26]Halldorsson S, Lucumi E, Gomez-Sjoberg R and Fleming RM, Biosens Bioelectron, 2015, 63, 218– 231. 25105943
- [27]Xu X, Farach-Carson MC and Jia X, Biotechnol Adv, 2014, 32, 1256– 1268. 25116894 PMC4171250
- [28]Caballero D, Kaushik S, Correlo VM, Oliveira JM, Reis RL and Kundu SC, Biomaterials, 2017, 149, 98– 115. 29024838
- [29]Jeong SY, Lee JH, Shin Y, Chung S and Kuh HJ, PLoS One, 2016, 11, e0159013. 27391808 PMC4938568
- [30]Pavesi A, Tan AT, Koh S, Chia A, Colombo M, Antonecchia E, Miccolis C, Ceccarello E, Adriani G, Raimondi MT, Kamm RD and Bertoletti A, JCI Insight, 2017, 2. PMC5472441 28614795
- [31]Aref AR and Barbie DA, Ex Vivo Engineering of the Tumor Microenvironment, Humana Press, Cham.
- [32]Canadas I, Thummalapalli R, Kim JW, Kitajima S, Jenkins RW, Christensen CL, Campisi M, Kuang Y, Zhang Y, Gjini E, Zhang G, Tian T, Sen DR, Miao D, Imamura Y, Thai T, Piel B, Terai H, Aref AR, Hagan T, Koyama S, Watanabe M, Baba H, Adeni AE, Lydon CA, Tamayo P, Wei Z, Herlyn M, Barbie TU, Uppaluri R, Sholl LM, Sicinska E, Sands J, Rodig S, Wong KK, Paweletz CP, Watanabe H and Barbie DA, Nat Med, 2018, DOI: 10.1038/s41591-018-0116-5. PMC6082722 30038220 · DOI
- [33]Kitajima S, Yoshida A, Kohno S, Li F, Suzuki S, Nagatani N, Nishimoto Y, Sasaki N, Muranaka H, Wan Y, Thai TC, Okahashi N, Matsuda F, Shimizu H, Nishiuchi T, Suzuki Y, Tominaga K, Gotoh N, Suzuki M, Ewen ME, Barbie DA, Hirose O, Tanaka T and Takahashi C, Oncogene, 2017, 36, 5145– 5157. 28481867
- [34]Terai H, Kitajima S, Potter DS, Matsui Y, Quiceno LG, Chen T, Kim TJ, Rusan M, Thai TC, Piccioni F, Donovan KA, Kwiatkowski N, Hinohara K, Wei G, Gray NS, Fischer ES, Wong KK, Shimamura T, Letai A, Hammerman PS and Barbie DA, Cancer Res, 2018, 78, 1044– 1057. 29259014 PMC5815936
- [35]Domcke S, Sinha R, Levine DA, Sander C and Schultz N, Nat Commun, 2013, 4, 2126. 23839242 PMC3715866
- [36]Katt ME, Placone AL, Wong AD, Xu ZS and Searson PC, Front Bioeng Biotechnol, 2016, 4, 12. 26904541 PMC4751256
- [37]Arrigoni C, Bersini S, Gilardi M and Moretti M, Int J Mol Sci, 2016, 17. PMC5037685 27571063
- [38]Herroon MK, Diedrich JD and Podgorski I, Front Endocrinol (Lausanne), 2016, 7, 84. 27458427 PMC4933721
- [39]Roudnicky F and Hollmen M, Genom Data, 2016, 8, 1– 3. 27081631 PMC4818341
- [40]Guiet R, Van Goethem E, Cougoule C, Balor S, Valette A, Al Saati T, Lowell CA, Le Cabec V and Maridonneau-Parini I, J Immunol, 2011, 187, 3806– 3814. 21880978 PMC4276309
- [41]Lallo A, Schenk MW, Frese KK, Blackhall F and Dive C, Transl Lung Cancer Res, 2017, 6, 397– 408. 28904884 PMC5583071
- [42]Krebs MG, Metcalf RL, Carter L, Brady G, Blackhall FH and Dive C, Nat Rev Clin Oncol, 2014, 11, 129– 144. 24445517
- [43]Pantel K and Alix-Panabieres C, Clin Chem, 2016, 62, 328– 334. 26637479
- [44]Pailler E, Adam J, Barthelemy A, Oulhen M, Auger N, Valent A, Borget I, Planchard D, Taylor M, Andre F, Soria JC, Vielh P, Besse B and Farace F, J Clin Oncol, 2013, 31, 2273– 2281. 23669222
- [45]Ross K, Pailler E, Faugeroux V, Taylor M, Oulhen M, Auger N, Planchard D, Soria JC, Lindsay CR, Besse B, Vielh P and Farace F, Expert Rev Mol Diagn, 2015, 15, 1605– 1629. 26564313
- [46]Pailler E, Faugeroux V, Oulhen M, Catelain C and Farace F, Transl Lung Cancer Res, 2017, 6, 444– 453. 28904888 PMC5583075
- [47]Drost J and Clevers H, Nat Rev Cancer, 2018, 18, 407– 418. 29692415
- [48]Broutier L, Mastrogiovanni G, Verstegen MM, Francies HE, Gavarro LM, Bradshaw CR, Allen GE, Arnes-Benito R, Sidorova O, Gaspersz MP, Georgakopoulos N, Koo BK, Dietmann S, Davies SE, Praseedom RK, Lieshout R, JNM IJ, Wigmore SJ, Saeb-Parsy K, Garnett MJ, van der Laan LJ and Huch M, Nat Med, 2017, 23, 1424– 1435. 29131160 PMC5722201
- [49]Sachs N, de Ligt J, Kopper O, Gogola E, Bounova G, Weeber F, Balgobind AV, Wind K, Gracanin A, Begthel H, Korving J, van Boxtel R, Duarte AA, Lelieveld D, van Hoeck A, Ernst RF, Blokzijl F, Nijman IJ, Hoogstraat M, van de Ven M, Egan DA, Zinzalla V, Moll J, Boj SF, Voest EE, Wessels L, van Diest PJ, Rottenberg S, Vries RGJ, Cuppen E and Clevers H, Cell, 2018, 172, 373– 386 e310. 29224780
- [50]Daniel VC, Marchionni L, Hierman JS, Rhodes JT, Devereux WL, Rudin CM, Yung R, Parmigiani G, Dorsch M, Peacock CD and Watkins DN, Cancer Res, 2009, 69, 3364– 3373. 19351829 PMC2821899
- [51]Morton CL and Houghton PJ, Nat Protoc, 2007, 2, 247– 250. 17406581
- [52]Voskoglou-Nomikos T, Pater JL and Seymour L, Clin Cancer Res, 2003, 9, 4227– 4239. 14519650
- [53]Girotti MR, Gremel G, Lee R, Galvani E, Rothwell D, Viros A, Mandal AK, Lim KH, Saturno G, Furney SJ, Baenke F, Pedersen M, Rogan J, Swan J, Smith M, Fusi A, Oudit D, Dhomen N, Brady G, Lorigan P, Dive C and Marais R, Cancer Discov, 2016, 6, 286– 299. 26715644
- [54]Gengenbacher N, Singhal M and Augustin HG, Nat Rev Cancer, 2017, 17, 751– 765. 29077691
- [55]Gould SE, Junttila MR and de Sauvage FJ, Nat Med, 2015, 21, 431– 439. 25951530
- [56]Frese KK and Tuveson DA, Nat Rev Cancer, 2007, 7, 645– 658. 17687385
Cited by
Sorted by citations
Intrinsic Immunogenicity of Small Cell Lung Carcinoma Revealed by Its Cellular Plasticity
Mahadevan, N. R., Knelson, E. H., Wolff, J. O., Vajdi, A., Saigí, M., Campisi, M., Hong, D., Thai, T. C., Piel, B., Han, S., et al. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-0913 · Cited by 227 · see citing works
Self-citationTrujillo-de Santiago, G., Flores-Garza, B. G., Tavares-Negrete, J. A., Lara-Mayorga, I. M., González-Gamboa, I., Zhang, Y. S., Rojas-Martínez, A., Ortiz-López, R., & Álvarez, M. M. (2019) · Materials · doi:10.3390/ma12182945 · Cited by 184 · see citing works
“[48-53] [54-72] Spheroids in microfluidic chambers Spheroids in a hydrogel matrix”
BackgroundMethodInfluentialTargeting TBK1 to overcome resistance to cancer immunotherapy
Sun, Y., Revach, O.-Y., Anderson, S., Kessler, E. A., Wolfe, C. H., Jenney, A., Mills, C. E., Robitschek, E. J., Davis, T. G. R., Kim, S., et al. (2023) · Nature · doi:10.1038/s41586-023-05704-6 · Cited by 174 · see citing works
Self-citationThree-dimensional bio-printing of primary human hepatocellular carcinoma for personalized medicine
Xie, F., Sun, L., Pang, Y., Xu, G., Jin, B., Xu, H., Lu, X., Xu, Y., Du, S., Wang, Y., et al. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2020.120416 · Cited by 147 · see citing works
Human biomimetic liver microphysiology systems in drug development and precision medicine
Gough, A., Soto-Gutierrez, A., Vernetti, L., Ebrahimkhani, M. R., Stern, A. M., & Taylor, D. L. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-00386-1 · Cited by 117 · see citing works
Engineering approaches for studying immune-tumor cell interactions and immunotherapy
Shelton, S. E., Nguyen, H. T., Barbie, D. A., & Kamm, R. D. (2021) · iScience · doi:10.1016/j.isci.2020.101985 · Cited by 93 · see citing works
Self-citationActivation of Tumor-Cell STING Primes NK-Cell Therapy
Knelson, E. H., Ivanova, E. V., Tarannum, M., Campisi, M., Lizotte, P. H., Booker, M. A., Ozgenc, I., Noureddine, M., Meisenheimer, B., Chen, M., et al. (2022) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-22-0017 · Cited by 88 · see citing works
Self-citationA microfluidic platform for functional testing of cancer drugs on intact tumor slices
Rodriguez, A. D., Horowitz, L. F., Castro, K., Kenerson, H., Bhattacharjee, N., Gandhe, G., Raman, A., Monnat, R. J., Yeung, R., Rostomily, R. C., et al. (2020) · Lab on a Chip · doi:10.1039/c9lc00811j · Cited by 77 · see citing works
Engineering microphysiological immune system responses on chips
Miller, C. P., Shin, W., Ahn, E. H., Kim, H. J., & Kim, D.-H. (2020) · Trends in biotechnology · doi:10.1016/j.tibtech.2020.01.003 · Cited by 74 · see citing works
3D Immunocompetent Organ‐on‐a‐Chip Models
Maharjan, S., Cecen, B., & Zhang, Y. S. (2020) · Small Methods · doi:10.1002/smtd.202000235 · Cited by 62 · see citing works
Toward improved <i>in vitro</i> models of human cancer
Ayuso, J. M., Park, K.-Y., Virumbrales-Muñoz, M., & Beebe, D. J. (2021) · APL Bioengineering · doi:10.1063/5.0026857 · Cited by 40 · see citing works
PDAC as an immune evasive disease: can 3D model systems aid to tackle this clinical problem?
Narayanan, S., Vicent, S., & Ponz-Sarvisé, M. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.787249 · Cited by 24 · see citing works
- Authors
- Aref, A. R., Campisi, M., Ivanova, E., Portell, A., Larios, D., Piel, B. P., Mathur, N., Zhou, C., Coakley, R. V., Bartels, A., Bowden, M., Herbert, Z., Hill, S., Gilhooley, S., Carter, J., Cañadas, I., Thai, T. C., Kitajima, S., Chiono, V., Paweletz, C. P., Barbie, D. A., Kamm, R. D., & Jenkins, R. W.
- Affiliations
- Dana-Farber Cancer Institute (US)
- Politecnico di Torino (IT)
- Department of Medical Oncology
- Massachusetts Institute of Technology (US)
- Harvard University (US)
- Corresponding author
- Jenkins, Russell W.
- ORCID
- Venue
- Lab on a Chip
- Publisher
- Royal Society of Chemistry (RSC)
- Published
- 2018
- Volume
- 18
- Issue
- 20
- Pages
- 3129-3143
- ISSN
- 1473-0189 (ISSN-L)
- 1473-0197
- PMC
- PMC6274590
- OpenAlex
- W2892074270
- Cited by
- 265
- References
- 11
- Citations by year
- 2026: 19 · 2025: 27 · 2024: 41 · 2023: 47 · 2022: 33 · 2021: 47 · 2020: 39 · 2019: 10 · 2018: 1 · 2017: 1
- FWCI
- 9.69
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Lab on a Chip (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- PORTO@Iris (submittedVersion, cc-by-nc)
- DSpace@MIT (Massachusetts Institute of Technology) (submittedVersion, cc-by-nc)
- The Royal Society of Chemistry
- Funders
- National Cancer Institute (CA190394-01, CA214381-01, T32CA009172-41)
- Massachusetts Institute of Technology (BIOMODE)
- Politecnico di Torino (BIOMODE)
- Compagnia di San Paolo
- American Cancer Society (SU2C-AACR-DT17-15)
- Topics
- Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
- Physical Sciences › Engineering › Biomedical Engineering › Microfluidic and Capillary Electrophoresis Applications
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Keywords
- immune checkpoint blockade, tumor-immune interactions, tumor microenvironment, cancer immunotherapy response prediction, precision oncology
- MeSH terms
- Animals, Immunity, Spheroids, Cellular, Cell Culture Techniques, Cell Line, Tumor, Mice, Lab-On-A-Chip Devices
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review